Created by Order 4757/17 of 31 May (MAFDR). Measure Nº1, entitled “Development of an oral vaccine, harmless and adjustable to the evolution of the virus”, falls within the Research Axis of the referred Plan, which also includes an Axis of Good Management Practices, an Axis of Sanitary Control and a Axis of Knowledge Dissemination and Dissemination.